Original Research
Accepted on 30 Dec 2025
Too Soon to Switch? Early TKI Switching vs. Continuous Monotherapy: Long-Term Outcomes in Chronic Myeloid Leukemia (CML)
in Blood Cancer
Frontiers in Hematology
- Frontiers in Hematology
- Blood Cancer
- Articles
Type at least 3 characters
79 articles
articles
Case Report
Accepted on 16 Dec 2025
Durable Response to PD-1 Blockade After Failure of ALK-Targeted Therapy and Chemoimmunotherapy in ALK-Positive Large B-Cell Lymphoma
in Blood Cancer
Frontiers in Hematology
- 357 views
Review
Accepted on 11 Dec 2025
To Treat or Not to Treat: A State-of-the-Art Overview of Smoldering Multiple Myeloma
in Blood Cancer
Frontiers in Hematology
- 431 views
Case Report
Accepted on 28 Nov 2025
A Converging Pathology: Chediak-Higashi Syndrome and IEI-Associated Lymphoproliferative Disease. Case Report
in Blood Cancer
Frontiers in Hematology
- 360 views
Original Research
Accepted on 26 Nov 2025
Myeloma patients' attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey
in Blood Cancer
Frontiers in Hematology
- 373 views
Brief Research Report
Published on 13 Nov 2025
Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1702446
- 1,056 views
Review
Published on 11 Nov 2025
A focus on LBCL patients in partial remission in the CAR-T era
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1675099
- 1,263 views
Case Report
Published on 10 Oct 2025
Case Report: Extramedullary plasmacytoma of the stomach: a rare manifestation of relapsed multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1655966
- 1,078 views
Systematic Review
Published on 02 Oct 2025
The role of interventional radiology in pain management for multiple myeloma: a literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1649720
- 1,574 views
Original Research
Published on 25 Sep 2025
H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1668408
- 1,470 views
Brief Research Report
Published on 25 Sep 2025
Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1638236
- 1,360 views
Brief Research Report
Published on 23 Sep 2025
Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1664425
- 1,753 views
Original Research
Published on 12 Sep 2025
Immune profile focusing on B-cell activating factor in B-cell malignancies
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1626886
- 1,441 views
Case Report
Published on 22 Aug 2025
Case report: A case of intravascular large B-cell lymphoma and related literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1639726
- 1,475 views
Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 2,382 views
Case Report
Published on 15 Jul 2025
Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1527938
- 1,197 views
Brief Research Report
Published on 11 Jul 2025
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1613099
- 1,279 views
Case Report
Published on 23 Jun 2025
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
- 792 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 3,584 views
- 2 citations
Case Report
Published on 18 Jun 2025
Successful management of acute promyelocytic leukemia in the third trimester of pregnancy: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1553336
- 1,904 views
- 2 citations
Original Research
Published on 23 May 2025
Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1479185
- 1,435 views
Original Research
Published on 14 May 2025
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1557641
- 1,920 views
Mini Review
Published on 13 May 2025
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
- 1,565 views
Original Research
Published on 06 May 2025
Disease and treatment burden in patients with leukaemia: family members/partner perspective
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
- 2,644 views
- 1 citation